Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Spelman

Showing results (201-210 of 266) with videos related to

Pageof 27
Sort By:
Journal of the Neurological Sciences|August 15, 2018
Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapyIlya Kister, Tim Spelman, Francesco Patti, et al.
Lung Cancer (Amsterdam, Netherlands)|December 10, 2025
Impact of PD-L1 on first-line osimertinib outcomes in EGFR-mutant NSCLC: real-world data from the AURORA25 study and meta-analysisMarliese Alexander, Malinda Itchins, Jonathan Felthun, et al.
Multiple Sclerosis and Related Disorders|June 17, 2023
Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registriesTereza Hrnciarova, Jiri Drahota, Tim Spelman, et al.
The New England Journal of Medicine|October 18, 2023
Trial of Vancomycin and Cefazolin as Surgical Prophylaxis in ArthroplastyTrisha N Peel, Sarah Astbury, Allen C Cheng, et al.
The Journal of Infectious Diseases|January 11, 2013
Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated agingEdwin Leeansyah, Paul U Cameron, Ajantha Solomon, et al.
Virology|July 27, 2010
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencingJennifer Audsley, Margaret Littlejohn, Lilly Yuen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2021
Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 StudyThomas A Rasmussen, Lakshmi Rajdev, Ajantha Rhodes, et al.
Neurology. Clinical Practice|January 29, 2021
Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MSAndrew Chan, John Rose, Enrique Alvarez, et al.
Life Science Alliance|June 11, 2020
Multiple sclerosis risk variants regulate gene expression in innate and adaptive immune cellsMelissa M Gresle, Margaret A Jordan, Jim Stankovich, et al.
European Urology Oncology|January 28, 2024
Fluorine-18-labelled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography or Magnetic Resonance Imaging to Diagnose and Localise Prostate Cancer. A Prospective Single-arm Paired Comparison (PEDAL)Lih-Ming Wong, Tom Sutherland, Elisa Perry, et al.
Pageof 27

Showing results (201-210 of 266) with videos related to

Sort By:
Pageof 27
Journal of the Neurological Sciences|August 15, 2018
Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapyIlya Kister, Tim Spelman, Francesco Patti, et al.
Lung Cancer (Amsterdam, Netherlands)|December 10, 2025
Impact of PD-L1 on first-line osimertinib outcomes in EGFR-mutant NSCLC: real-world data from the AURORA25 study and meta-analysisMarliese Alexander, Malinda Itchins, Jonathan Felthun, et al.
Multiple Sclerosis and Related Disorders|June 17, 2023
Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registriesTereza Hrnciarova, Jiri Drahota, Tim Spelman, et al.
The New England Journal of Medicine|October 18, 2023
Trial of Vancomycin and Cefazolin as Surgical Prophylaxis in ArthroplastyTrisha N Peel, Sarah Astbury, Allen C Cheng, et al.
The Journal of Infectious Diseases|January 11, 2013
Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated agingEdwin Leeansyah, Paul U Cameron, Ajantha Solomon, et al.
Virology|July 27, 2010
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencingJennifer Audsley, Margaret Littlejohn, Lilly Yuen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2021
Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 StudyThomas A Rasmussen, Lakshmi Rajdev, Ajantha Rhodes, et al.
Neurology. Clinical Practice|January 29, 2021
Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MSAndrew Chan, John Rose, Enrique Alvarez, et al.
Life Science Alliance|June 11, 2020
Multiple sclerosis risk variants regulate gene expression in innate and adaptive immune cellsMelissa M Gresle, Margaret A Jordan, Jim Stankovich, et al.
European Urology Oncology|January 28, 2024
Fluorine-18-labelled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography or Magnetic Resonance Imaging to Diagnose and Localise Prostate Cancer. A Prospective Single-arm Paired Comparison (PEDAL)Lih-Ming Wong, Tom Sutherland, Elisa Perry, et al.
Pageof 27